IgA deficiency
in celiac disease
in celiac disease
IgA is the abbreviation for immunoglobulin A and refers to a group of antibodies that perform a specific task as part of our immune system. They are primarily found on mucous membranes, such as in the gastrointestinal tract and respiratory tract. In this article, I would like to explain what they have to do with celiac disease and how a deficiency affects the body. Below, you can also download a checklist and the detailed procedure for diagnosing an IgA deficiency.
In another post, I have already explained the basic structure of our immune system and the role antibodies play in it. To repeat it briefly here: Antibodies are specifically produced by certain white blood cells (B lymphocytes) to target foreign substances such as viruses. This allows our immune system to combat these pathogens in a very targeted manner. Since the antibody must first be "manufactured"—a kind of tailor-made solution—it takes a little longer until it is available. However, our immune system remembers the contact, so that upon the second encounter with the same virus, the antibody can be reactivated very quickly.
Our immune system can produce different antibody groups, as I explain in more detail in the previous post. But here is a very brief summary again: there are antibodies of groups A, E, G, and M. They are also known as immunoglobulins, which leads to the abbreviations IgA, IgE, IgG, and IgM. In this post, I would like to focus on IgA:
Immunoglobulin A, or IgA for short, is primarily produced in mucous membranes and body fluids, thus representing a first and important barrier against invading foreign substances and pathogens. For this reason, it is found in larger quantities in the intestinal mucosa and respiratory tract, but also in tears, saliva, or breast milk. Pathogens can therefore be intercepted at the border of the mucous membrane and rendered harmless.
I have already explained that antibodies are only formed over the course of life through contact with foreign substances and pathogens. The IgA antibody group is also not present to the same extent from birth as it is later in life. Newborns do not yet have measurable levels in their blood. These levels then rise slowly during the first few years of life, and stable IgA production can be assumed from about the age of 4. If the values are still very low, an IgA deficiency might be present. In adults, the measured value should be between 70 and 400 mg/dl (or 0.7–4.0 g/l). You can find age-appropriate reference values in the table.
With an incidence of approximately one in 500-700 people, IgA deficiency is the most common immunodeficiency in our population. In most cases, this involves a so-called selective IgA deficiency, meaning that only IgA production is impaired. Combined immunodeficiencies also occur, which involve other antibody groups or other components of the immune system.
Since IgA production is generally quite low in the first few years of life, these threshold values for a deficiency only apply after the fourth birthday.
You probably think that an immunodeficiency should be immediately apparent, especially when the first line of defense against pathogens on the mucous membranes is missing. This is certainly true – about half of the people with an IgA deficiency show an increased susceptibility to infection, particularly to bacterial infections such as otitis media and upper respiratory tract infections. In fact, they also more frequently develop chronic inflammatory bowel diseases and autoimmune diseases such as celiac disease, as well as others affecting the thyroid or those within the rheumatological spectrum. About one third of the individuals who are symptomatic with IgA deficiency have an additional autoimmune disease. Allergies are also observed more frequently, occurring in the respiratory tract in the form of hay fever or asthma, on the skin as allergic eczema, or in the gastrointestinal tract as a food allergy.
However, the other half of those affected have no symptoms of this immune deficiency. This is because our immune system is so complex that its various components can complement and compensate for one another. As a result, an IgA deficiency often remains undiagnosed – until the blood levels are tested for IgA antibodies and it is discovered that they are too low.
Moreover, a single low IgA reading does not immediately mean that one has a deficiency. This occasionally occurs temporarily, so it makes sense to recheck a low IgA value after 1–2 months.
If an IgA deficiency is diagnosed, other antibodies, namely IgM and IgG, should also be examined to determine the extent of the immune defect. Regular check-ups (every 2 years) of IgG levels are advisable, as there may be an additional loss of this immune function over time.
As I wrote above, celiac disease occurs more frequently in people with an IgA deficiency. Depending on the study, the prevalence is between 2 and 8%, compared to about one percent in the general population. The lack of this primary antibody barrier allows for a more altered immune response to food components and can therefore contribute to the development of this autoimmune disease. Furthermore, the immune system seems more prone to an autoimmune reaction due to the defect.
While celiac disease is more common with IgA deficiency, this significantly complicates the diagnosis of celiac disease in these patients:
IgA antibodies, such as the tissue transglutaminase IgA antibody (abbr.: tTG-IgA-Ab), are predominantly used in the diagnosis of celiac disease. However, if a person cannot form IgA antibodies because they have an absolute IgA deficiency, they will not produce IgA-type celiac antibodies either. A negative antibody test is interpreted by many doctors and other individuals as meaning there is no suspicion of celiac disease. Since IgA deficiency is often undiagnosed, one would not notice that the patient is unable to produce celiac-specific IgA antibodies. Therefore, a total IgA level must always be tested, at least the first time. Only then can a negative celiac IgA antibody result be interpreted correctly:
If there is a suspected case of celiac disease and the tTG-IgA antibody values are unremarkable, but an IgA deficiency has been confirmed at the same time, further examinations are necessary: In addition to celiac disease IgA antibodies, corresponding IgG antibodies can also be tested. These are used in the event of an IgA deficiency – and only then. Otherwise, IgG antibodies provide no additional benefit and only result in increased costs.
You can test for both IgG antibodies against tissue transglutaminase and against deamidated gliadin peptides (abbrev.: DGP). Both tests can be performed as an alternative; it is not necessary to perform both.
Deamidated gliadin peptides are formed during the digestion of gluten. Our intestines cannot break down gluten into its smallest protein building blocks (= amino acids). We lack the corresponding digestive enzymes for this. Consequently, somewhat longer protein fragments (= peptides) remain, which are slightly chemically altered—deamidated—as they are absorbed into the body through the intestinal lining. This is how deamidated gliadin peptides are formed, and in cases of celiac disease, antibodies are produced against them.
If the IgG antibody against tTG or DGP is abnormal, a gastroscopy with a small intestinal biopsy must be performed next to confirm celiac disease. In this case, there is no way to reliably diagnose celiac disease in either children or adults without this procedure. The diagnosis of celiac disease is then established from these two examinations, with elevated tTG or DGP IgG antibodies and clearly altered mucosa in the duodenum.
Individuals with a relative IgA deficiency are able to produce a certain level of IgA antibodies. If elevated tTG-IgA antibodies can be detected in them, the standard procedure can also be used even if total IgA is (slightly) below the age-appropriate norm. If total IgA is below the norm, even if only slightly, and the tTG-IgA antibody is not conclusive, then the IgG antibody against tTG or DGP must always be tested subsequently.
I know this is a lot of information, so I would like to summarize it for you here once again:
IgA deficiency is a common immune defect in our population and remains asymptomatic and therefore undetected in half of those affected.
IgA deficiency frequently occurs in conjunction with autoimmune diseases such as celiac disease.
In cases of IgA deficiency, standard blood tests for celiac disease are not very conclusive. Therefore, a total IgA level must always be checked as well in order to correctly evaluate the celiac antibody.
In the case of an IgA deficiency, IgG antibodies against tissue transglutaminase (TTG) or against deamidated gliadin peptides (DGP) are used.
If elevated IgG antibodies against tTG or DGP are found, a gastroscopy with a small intestine biopsy must be performed to confirm celiac disease.